• Current interests

    • JIA and complementary therapies
    • Immunisation of children with JIA on immunosuppressant therapy
    • Evaluation of the rheumatology best practice model of care
    • Clinical trials: Tocilizumab, Tofacitinib
    • CLARITY: the JIA Biobank
    • JACS: the Juvenile Arthritis Cohort Study

    Contact 03 9345 4162 for more information about any of our research projects.

    Funding received